Dave was diagnosed with AML, Acute Myeloid Leukemia, on August 21, 2017 by Dr. Elihu Estey, Seattle Cancer Care Alliance. We came to Seattle on August 26, 2017 and he started an experimental drug trial on August 29, 2017. He has had two set of chemo treatments thus far. He is in remission--no leukemia cells were found. He will join the Transplant Team on December 12, 2017. We moved to the following address, which is our mailing address: David Lindeblad, c/o Pete Gross House, 525 Minor Ave. North, Apt. 213, Seattle WA 98109.